Please login to the form below

Not currently logged in
Email:
Password:

ASCO

This page shows the latest ASCO news and features for those working in and with pharma, biotech and healthcare.

Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

The treatments are larotrectinib - which could be mere weeks away from a US filing after positive phase II data was reported at this year’s American Society of Clinical Oncology (ASCO) ... In the ASCO trials, larotrectinib achieved a 76% objective

Latest news

More from news
Approximately 17 fully matching, plus 90 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • How did pharma use Twitter at #ASCO16?

    How did pharma use Twitter at #ASCO16? Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how ... ASCO’ s Annual Meeting has led the way in terms of social

  • ASCO 2015: What you missed in Chicago

    Three monoclonal antibodies were presented on the last day of ASCO - two in multiple myeloma and one in amyloidosis. ... ASCO 15: Highlighting innovation and raising key questions. Amgen and AstraZeneca had excellent booths that were extremely

  • Ashfield

    Each year, ASCO’ s Annual Meeting brings together 30, 000 oncology professionals from around the world, here we explore the #ASCO16 hashtag and how pharma utilised the channel during this

  • The heart of the matter: Part Two

    Meanwhile, among the mainstream social channels. Twitter in particular clearly resonates as a tool within the medical community at congresses - this year’ s ASCO meeting even saw the American Society of

  • Blue Latitude Health

    ASCO 2015: What you missed in Chicago. ... Blue Latitude sent two of our consultants to Chicago to attend ASCO 2015, a key annual meeting for oncology specialists that brings over 30, 000 delegates together to talk about innovations

More from PMHub
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics